Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma

Fig. 5

Genomic alterations and promoter methylation of NR1H4. A 6% mutation rate of NR1H4 was observed in ccRCC patients. Genetic alterations in NR1H4 were associated with shorter OS (B) and PFS (C) of ccRCC patients. D The DNA methylation level of NR1H4 in ccRCC patients and the Kaplan–Meier curves for survival analysis of DNA methylation of NR1H4 between high- and low-risk groups

Back to article page